<SEC-DOCUMENT>0001104659-17-010092-index.html : 20170217
<SEC-HEADER>0001104659-17-010092.hdr.sgml : 20170217
<ACCEPTANCE-DATETIME>20170217104221
ACCESSION NUMBER:		0001104659-17-010092
CONFORMED SUBMISSION TYPE:	POSASR
PUBLIC DOCUMENT COUNT:		9
FILED AS OF DATE:		20170217
DATE AS OF CHANGE:		20170217
EFFECTIVENESS DATE:		20170217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVARTIS AG
		CENTRAL INDEX KEY:			0001114448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POSASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-207004
		FILM NUMBER:		17620168

	BUSINESS ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		CITY:			BASEL
		STATE:			V8
		ZIP:			CH 4056
		BUSINESS PHONE:		01141613241111

	MAIL ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		CITY:			BASEL
		STATE:			V8
		ZIP:			CH 4056

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Novartis Capital CORP
		CENTRAL INDEX KEY:			0001443411
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				263086456
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POSASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-207004-02
		FILM NUMBER:		17620169

	BUSINESS ADDRESS:	
		STREET 1:		608 FIFTH AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		(212)307 1122

	MAIL ADDRESS:	
		STREET 1:		608 FIFTH AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Novartis Securities Investment Ltd.
		CENTRAL INDEX KEY:			0001443663
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POSASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-207004-01
		FILM NUMBER:		17620170

	BUSINESS ADDRESS:	
		STREET 1:		131 FRONT STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM 12
		BUSINESS PHONE:		(1)441 296 8025

	MAIL ADDRESS:	
		STREET 1:		P.O.BOX  HM 2899
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM LX
</SEC-HEADER>
<DOCUMENT>
<TYPE>POSASR
<SEQUENCE>1
<FILENAME>a17-4530_1posasr.htm
<DESCRIPTION>POST-EFFECTIVE AMENDMENT NO.2
<TEXT>
Document 1 - file: a17-4530_1posasr.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>a17-4530_1ex4d6.htm
<DESCRIPTION>FORM OF GUARANTEED DEBT SECURITY FOR 1.800% NOTES DUE 2020
<TEXT>
Document 2 - file: a17-4530_1ex4d6.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>3
<FILENAME>a17-4530_1ex4d7.htm
<DESCRIPTION>FORM OF GUARANTEED DEBT SECURITY FOR 2.400% NOTES DUE 2022
<TEXT>
Document 3 - file: a17-4530_1ex4d7.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>4
<FILENAME>a17-4530_1ex4d8.htm
<DESCRIPTION>FORM OF GUARANTEED DEBT SECURITY FOR 3.100% NOTES DUE 2027
<TEXT>
Document 4 - file: a17-4530_1ex4d8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>5
<FILENAME>a17-4530_1ex4d9.htm
<DESCRIPTION>OFFICER'S CERTIFICATE OF NOVARTIS CAPITAL CORPORATION
<TEXT>
Document 5 - file: a17-4530_1ex4d9.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.6
<SEQUENCE>6
<FILENAME>a17-4530_1ex5d6.htm
<DESCRIPTION>OPINION OF MAYER BROWN INTERNATIONAL LLP
<TEXT>
Document 6 - file: a17-4530_1ex5d6.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.7
<SEQUENCE>7
<FILENAME>a17-4530_1ex5d7.htm
<DESCRIPTION>OPINION OF BAER & KARRER AG
<TEXT>
Document 7 - file: a17-4530_1ex5d7.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g45301ksi001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: g45301ksi001.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g45301kui001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: g45301kui001.jpg

</DOCUMENT>
</SEC-DOCUMENT>